Revenue
395 thousand USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 395000 USD Source
Market value
$156.49M
54,811,391 shares as of 2026-11-06, at $2.855 a share (UPB, IEX close on 2026-11-12) Primary-source evidence
Annual consolidated revenue for 2025: about USD 2.854M, using the latest reported figures. The previous period, 2024, was about USD 2.37M.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-19.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
395 thousand USD
2026 Q3 · USD
-10,982.03%
2026 Q3 · %
-54.2 million USD
2026 Q3 · USD
-54.2 million USD
2026 Q3 · USD
47416000 USD
54811391 shares
1.50% · 812 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
2.87 million USD
2025-10-01 – 2026-09-30
-164 million USD
2025-10-01 – 2026-09-30
-168 million USD
2025-10-01 – 2026-09-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-10.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 2.37 million
–
Current period
USD 2.85 million
–
2854000 − 2370000 = 484000 USD
2370000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source2854000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 62.81 million
–
Current period
−USD 143.44 million
–
-143443000 − -62806000 = -80637000 USD
-62806000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-143443000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 59.17 million
–
Current period
−USD 133.28 million
–
-133275000 − -59172000 = -74103000 USD
-59172000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-133275000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 511,000
–
Current period
USD 165,000
–
165000 − 511000 = -346000 USD
511000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source165000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | 2380000 | 42494000 Derived | -40114000 | -19577000 Derived | -20537000 | -38070000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 2370000 | 80134000 Derived | -77764000 | -14958000 Derived | -62806000 | -59683000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 2854000 | 163215000 Derived | -160361000 | -16918000 Derived | -143443000 | -133440000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 2380000 |
|
| 2024 | Revenue | 2370000 |
|
| 2025 | Revenue | 2854000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | -0.4% |
|
| 2025 | Year over year | 20.4% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | -1,685.5% |
|
| 2024 | Operating margin | -3,281.2% |
|
| 2025 | Operating margin | -5,618.8% |
|
| 2023 | Net margin | -862.9% |
|
| 2024 | Net margin | -2,650% |
|
| 2025 | Net margin | -5,026% |
|
| 2023 | Free cash flow margin | -1,599.6% |
|
| 2024 | Free cash flow margin | -2,518.3% |
|
| 2025 | Free cash flow margin | -4,675.5% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | -37926000 |
|
| 2024 | Operating cash flow | -59172000 |
|
| 2025 | Operating cash flow | -133275000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | -38070000 |
|
| 2024 | Free cash flow | -59683000 |
|
| 2025 | Free cash flow | -133440000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Liabilities / assets | 8% |
|
| 2024 | Liabilities / assets | 2.5% |
|
| 2025 | Liabilities / assets | 4% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Current assets / current liabilities | 17.96× |
|
| 2024 | Current assets / current liabilities | 44.63× |
|
| 2025 | Current assets / current liabilities | 26.15× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | −USD 20.54 million Exact valueExact value: -20537000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 37.93 million Exact valueExact value: -37926000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 144,000 Exact valueExact value: 144000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 38.07 million Calculation and evidence-37926000 − 144000 USD Exact free cash flow: -38070000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 62.81 million Exact valueExact value: -62806000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 59.17 million Exact valueExact value: -59172000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 511,000 Exact valueExact value: 511000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 59.68 million Calculation and evidence-59172000 − 511000 USD Exact free cash flow: -59683000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 143.44 million Exact valueExact value: -143443000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 133.28 million Exact valueExact value: -133275000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 165,000 Exact valueExact value: 165000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 133.44 million Calculation and evidence-133275000 − 165000 USD Exact free cash flow: -133440000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
13 filings · 772 latest values · 772 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0002022626, 2022626, UPB, edgar:2022626
Also known as UPSTREAM BIO, INC., Upstream Bio, Inc.